# FDA Inspection 1141571 - Keila Hoover, M.D. - April 29, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/keila-hoover-md/e0ccd356-c77c-49df-b404-b4a48f12e46e
Source feed: FDA_Inspections

> FDA Inspection 1141571 for Keila Hoover, M.D. on April 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141571
- Company Name: Keila Hoover, M.D.
- Inspection Date: 2021-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274493 - 2025-06-26](https://www.globalkeysolutions.net/records/fda_inspections/keila-hoover-md/25bb7266-fced-4c7f-b3d5-39c62fd45138)
- [FDA Inspection 1274493 - 2025-06-26](https://www.globalkeysolutions.net/records/fda_inspections/keila-hoover-md/dc7c1037-536d-4297-8a96-57a760af983d)
- [FDA Inspection 1127347 - 2020-08-12](https://www.globalkeysolutions.net/records/fda_inspections/keila-hoover-md/fec5b04d-69e4-4587-b5cc-5bbba980db0a)
- [FDA Inspection 1127347 - 2020-08-12](https://www.globalkeysolutions.net/records/fda_inspections/keila-hoover-md/51e968f3-019f-474b-b1ac-8385d44e9ea5)

Company: https://www.globalkeysolutions.net/companies/keila-hoover-md/ed57f1de-f8bb-4cad-beed-01aa603961c0

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c